New Bevacizumab Data Fails to Support Use in Advanced Breast Cancer

posted on Jul 17 by MedPage Today OB/Gyn in the Uncategorized category WASHINGTON (MedPage Today) -- Adding bevacizumab (Avastin) to chemotherapy drugs doesn't increase survival for women with advanced breast cancer, according to FDA documents posted in advance of an advisory panel meeting on Tuesday.